Abstract:KEYWORDS: Drug design and development (DDD) is a lengthy and time-consuming process. The process can take up to 14–15 years, and the cost ranges from US 2,826 million (2019 estimate), and these costs keep rising [ Citation 1 ]. For several decades, computers have played a key role in DDD. The application of an extensive group of computational or in silico tools are referred to as computer-aided drug design (CADD), which have been used in academia and industry for several years [ Citation 2 ]. CADD is an interdisciplinary field and has become one of the pillars in the pharmaceutical discovery pipelines. Current significant technological advances that are transforming CADD into computationally-driven drug discovery (CDDD) include but are not limited to [ Citation 3 ]: large (10 6 –10 7 ) compound libraries in stock; ultra-large (10 10 –10 15 ) on-demand, and generative virtual libraries (10 23 –10 60 ); advances in structure-based and artificial intelligence (AI)-based virtual screening of the large and ultra-large spaces; de novo design; free energy perturbation and AI-based QSAR/QSPR modeling to enhance potency and selectivity; data-driven computational tools to predict absorption, distribution, metabolism, excretion, and bioactivity, and toxicology. The latter predictions are now routinely used in multiparameter hit-to-lead optimization. However, any computational model – regardless of its accuracy and applicability – will never ensure that all the predictions are correct. Strictly speaking, exact prediction of an experimental value is not possible as any experimental determination also has a degree of uncertainty. Computational predictions require experimental validation with appropriate and robust in vitro and in vivo assays. In turn, the experimental data can be fed back into the models to improve the quality [ Citation 3 , Citation 4 ]. In addition, as discussed in Section 2, AI plays a key role in synthesis planning and computational approaches that are used in the wet lab as part of the DDD automatization process.

The New Era of Drug Discovery: The Power of Computer-aided Drug Design (CADD)

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies

Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis

Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis

Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs

COMPUTER AIDED DRUG DESIGN: AN OVERVIEW

Applications of Computer-Aided Drug Design

A Guide to In Silico Drug Design

Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD)

i Drug: a web-accessible and interactive drug discovery and design platform

Research on the application of computer in drug design

What is the plausibility that all drugs will be designed by computers by the end of the decade?

Research on targeted drug design based on computer technology

Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action

Recent Trends in Drug Design and Discovery

Advances in computer-aided drug design for type 2 diabetes

A Review on Computational Software Tools for Drug Design and Discovery

Rational, computer-enabled peptide drug design: principles, methods, applications and future directions

SmartCADD: AI-QM Empowered Drug Discovery Platform with Explainability

Drug Design—Past, Present, Future